Genetics of the renin-angiotensin system and renal disease: A progress report

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 2, 1997, Pages 146-151

  Schmidt, Susanne ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMORPHISM; HUMAN; KIDNEY DISEASE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0030991317     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199703000-00007     Document Type: Review

References (57)

1. Schmidt S, Ritz E: The role of angiotensin I-converting enzyme gene polymorphism in renal disease. Curr Opin Nephrol Hypertens 1996, 5:552-555.
2. Yoshida H, Kon V, Ichikawa I: Polymorphisms of the renin-angiotensin system genes in progressive renal diseases [Editorial review]. Kidney Int 1996, 50:732-744.
3. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene T-T, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationship between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic retinopathy and renal complications. Diabetes 1994, 43:384-388.
4. Marre M, and Genediab Study Group: Angiotensin I converting enzyme and angiotensinogen polymorphisms interact for diabetic nephropathy development. Diabetologia 1996, 39(suppl 1):A60.
5. Barnas U, Schmidt A, Illievich A, Rabensteiner D, Prager R, Mayer G: The ACE gene polymorphism in patients with diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995, 6:1036.
6. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995, 44:489-494. This is the first study in a large cohort of type-1 diabetic patients where an association of the ACE-gene polymorphism with diabetic nephropathy was not confirmed.
7. Schmidt S, Schöne N, Ritz E, and the Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995, 47:1176-1181. This study examined for the first time the ACE gene polymorphism in patients with type-2 diabetes. No association of the ACE gene polymorphism with diabetic nephropathy was observed.
8. Bilo HJG, Thijssen S, de Knijff P, Stehouwer CDA, Kluft C: ACE- and ANG gene polymorphism and diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995, 6:1037.
9. Dudley CRK, Keavney B, Statton IM, Turner RC, Ratcliffe PJ: U.K. Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995, 48:1907-1911. This study on patients with type-2 diabetes showed that patients with persistent microalbuminuria have the DD-genotype more frequently.
10. Fujisawa T, Ikegami H, Shen G-Q, Yamamoto E, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J, Ohishi M et al.: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995, 18:983-985.
11. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995, 70:455-459.
12. Doi Y, Yoshizumi M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996, 39:97-102.
13. Ohno T, Kawazu S, Tomono S: Association of the polymorphism of the angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin dependent diabetics. Metabolism 1996, 45:218-222.
14. Richart C, Aguilar C, Broch M, Gutiérrez C, Llor C, Vendrell J: Renin-angiotensin system genes and long-term complications in NIDDM patients. Diabetologia 1996, 39(suppl 1):A288.
15. Solini A, Sfriso A, Trevisan M, Inchiostro S, Bueti A, Santeuasanio F, Faronata PP, Maioli M, Tonolo GC, Crepaldi G, Nosadini R: Analysis of ACE polymorphism in sib-pairs concordant for NIDDM and microalbuminuria. Diabetologia 1996, 39(suppl 1):A74.
16. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella G: Angiotensin converting enzyme insertion/ deletion polymorphism: association with ethnic origin. J Hypertens 1994, 12:955-957.
17. Froguel F, Hager J, Vionnet N: The genetics of type II diabetes. Curr Opin Endocrinol Diabetes 1995, 2:285-289.
18. Tiret L, Cambien F: Departure from Hardy-Weinberg equilibrium should be systematically tested in studies of association between genetic markers and disease [Letter]. Circulation 1995, 92:3364-3365.
19. Shanmugan V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Applications 1993, 3:120-121.
20. Freire MBS, Doshi R, Yang Y, Warram JH, Krolewski AS: Examining candidate genes for diabetic nephropathy [Abstract]. J Am Soc Nephrol 1996, 6:1869.
21. Pfohl M, Frost D, Koch M, Clemens P, Patzies A, Schmülling RM, Beischer W, Häring H-U: Relationship between angiotensin I converting enzyme (ACE) gene polymorphism and diabetic retinopathy and nephropathy in IDDM. Diabetologia 1996, 39(suppl 1):A61.
22. Tarnow L, Rossing P, Jacobsen P, Nielsen FS, Cambien F, Lecerf L, Poirier O, Parving HH: Progression of diabetic nephropathy and the insertion/deletion polymorphism (ACE I/D) of the angiotensin-I-converting enzyme gene [Abstract]. J Am Soc Nephrol 1996, 6:441.
23. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K et al.: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996, 50:657-664.
24. Parving H-H, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F: Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Br Med J 1996, 313:591-594. This is the first study examining the relation of the ACE gene polymorphism with susceptibility to ACE inhibitor treatment. Although the study was carried out in a cohort of limited size, tantalizing results are reported.
25. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe A, Clarkson AR, Ponticelli C, Campise M, Mayer G et al.: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995, 5:727-731.
26. Harden PN, Geddes C, Rowe PA, Mcllroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC, Jardine AG: Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542. This is the first study examining the role of the ACE gene polymorphism in progression of IgA-nephropathy.
27. Hunley TE, Julian BA, Phillips JA, Summer ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
28. Ogura M, Yoshida H, Kawamura T, Hamaguchi A, Miyazaki Y, Mitarai T, Okada T, Eto T, Kitajima T, Sakai O: The impact of the ACE gene polymorphism on slowly progressive IgA nephropathy may be linked to the glomerular size [Abstract]. J Am Soc Nephrol 1995, 6:398.
29. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995, 96:2162-2169. This is the first study examining the relation of the angiotensinogen gene polymorphism to the antiproteinuric effect of ACE inhibitor treatment.
30. Schmidt A, Kiener HP, Barnas U, Arias I, Illievich A, Auinger M, Graninger W, Kaider A, Mayer G: Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 1996, 7:314-317.
31. Hashimoto K, Iino Y, Ohsono E, Kawabe M, Hayama N, Terashi A: Association of angiotensin converting enzyme gene polymorphism with end-stage renal disease [Abstract]. J Am Soc Nephrol 1996, 7:1319.
32. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JMC, Jardine AG: The role of genetic polymorphism of angiotensin converting enzyme in the progression of renal diseases. Hypertension 1996, 28:912-915.
33. Hamaguchi A, Yoshida H, Miyazaki Y, Kawamura T, Mitarai T, Sakai O: The deletion polymorphism in the ACE gene is a risk factor for progression to renal failure independent of the M235T polymorphism in the angiotensinogen gene [Abstract]. J Am Soc Nephrol 1995, 6:389.
34. Missouris CG, Barley J, Jeffrey S, Carter ND, Singer DRJ, MacGregor GA: Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-conveting enzyme gene. Kidney Int 1996, 46:534-537.
35. Satoh H, Akai Y, Iwano M, Kurumatani N, Kurioka H, Kubo A, Yamaguchi T, Shiiki H, Fujimoto T, Dohi K: Association of an insertion polymorphism of angiotensin-converting enzyme gene with activity of Japanese Lupus Nephritis [Abstract]. J Am Soc Nephrol 1996, 7:1324.
36. Xu Y, Yoshida H, Tsunoda Y, Shiraga H, Hattori M, Iwamoto N, Kawaguchi H, Ito K, Yoshioka T: The deletion polymorphism of the angiotensin converting enzyme (ACE) gene predicts persistent proteinuria in Henoch-Schönlein Purpura Nephritis (HSPN) [Abstract]. J Am Soc Nephrol 1996, 7:1346.
37. Cheong HI, Park HW, Choi Y: Role of the angiotensin I converting enzyme (ACE) gene polymorphism in the development of reflux nephropathy (RNP) in children with vesico-ureteral reflux (VUR) [Abstract]. J Am Soc Nephrol 1996, 7:1383.
38. Perrichot R, Raguenes O, Mercier B, Whebe B, Lenormand JP, Ferec C, Cledes J: Genetic variation in the renin angiotensin system and membranous glomerulonephritis [Abstract]. J Am Soc Nephrol 1996, 7:1779.
39. Broekroelofs J, Stegeman CA, Navis GJ, Scheffer H, Tegzess AM, de Zeeuw D, de Jong PE: Is donor or recipient ACE genotype associated with long-term graft survival after renal transplantation (RT)? [Abstract]. J Am Soc Nephrol 1996, 7:1903.
40. Bourbigot B, Abalain JH, Carre JL, Hourmant MC, Moal JM, Duemymes JM, Lamour A, Whebe B, Floch HH: Angiotensin converting enzyme genotype in post renal transplant erythrocytosis [Abstract]. J Am Soc Nephrol 1996, 7:1903.
41. Moriyama T, Kitamura H, Ochi S, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E: Association of angiotensin converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995, 6:1674-1678.
42. Kiyama S, Nonoguchi H, Tajima A, Shimada H, Tomita K: Impact of angiotensin converting enzyme (ACE) gene polymorphism on renoprotective effect of ACE inhibitor (ACE-I) in the patients with chronic renal failure [Abstract]. J Am Soc Nephrol 1996, 7:1616.
43. ••].
44. Schmidt A, Haas M, Ylmaz N, Mayer G: Angiotensin converting enzyme polymorphism determines the renal response to ACE inhibition in patients with proteinuric kidney disease [Abstract]. J Am Soc Nephrol 1996, 7:1398.
45. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95. This study shows that the ACE gene polymorphism is not related to susceptibility to antihypertensive treatment.
46. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol C: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
47. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, Distler A, Ritz E: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset Nephrol Dial Transplant 1995, 10:1145-1148.
48. Geberth S, Stier E, Zeier M, Mayer G, Rambausek M, Ritz E: More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. Am J Soc Nephrol 1995, 6:1643-1648.
49. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving H-H: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996, 45:367-369. In this study examining patients with type-1 diabetes, no association of the angiotensinogen gene polymorphism with diabetic nephropathy was found.
50. Schmidt S, Gießel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E and the Diabetic Nephropathy Study Group: Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996, 11:1755-1761. No association of the angiotensinogen gene polymorphism with diabetic nephropathy in type 2 diabetes was observed.
51. Fogarty DG, Harron JC, Hughes AE, Doherty CC, Maxwell AP: The association of an angiotensinogen gene variant with diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995, 6:449.
52. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 1996, 27:1134-1139.
53. McLaughlin KJ, Jagger C, Small M, Jardine AG: Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus. Lancet 1995, 346:1160.
54. Schmidt S, Bahnisch J, Campise M, Clarkson AR, Ferrario F, Ponticelli C, Ritz E: The angiotensinogen gene M235T polymorphism and IgA nephropathy [Abstract]. J Am Soc Nephrol 1996, 7:1863.
55. Tarnow L, Cambien F, Rossing P, Flemming SN, Hansen BV, Ricard S, Poirier O, Parving H-H: Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996, 11:1019-1023. This is the only study examining the angiotensin II type-1 receptor gene polymorphism in patients with type-1 diabetes. No association with diabetic nephropathy was observed.
56. 1) receptor and diabetic nephropathy [Abstract]. J Am Soc Nephrol 1996, 7:1364.
57. Yoshida H, Hamaguchi A, Shimoda M, Eto T, Kawamura T, Hunley T, Kon V, Mitarai T, Sakai O: Does the A1166C polymorphism in the angiotensin type 1 receptor gene have an influence on the progression to renal failure? [Abstract]. J Am Soc Nephrol 1995, 6:409.